ISPC
iSpecimen Inc.Company Information
- Company Name
- iSpecimen Inc.
- CIK
- CIK0001558569
- Category
- <br>Emerging growth company
- Ticker: Exchange
- ISPC: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8731
- SIC Description
- Services-Commercial Physical & Biological Research
- Ticker
- ISPC
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-09-14
- Last sale
- —
- Shares purchased (TTM)
- 22,400
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 56,975
- Shares outstanding
- 1,394,482
- Ownership
- 4.09%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -31.56%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Series C Preferred Stock | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 3 | 7 | 3 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | ||||||
| Available For Sale Securities Debt Securities Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 3 | 3 | ||||||
| Unbilled Receivables Current | - | - | - | - | - | - | - | 2 | 2 | 2 | 2 | 1 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 2 | ||||||
| Inventory Net | - | - | - | - | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 4 | 3 | 7 | 4 | 1 | 2 | 4 | 5 | 5 | 5 | 8 | 9 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Capitalized Computer Software Net | 3 | 3 | 1 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 7 | ||||||
| Other Intangible Assets Net | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Assets | 7 | 7 | 10 | 9 | 6 | 7 | 9 | 11 | 12 | 13 | 16 | 16 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | ||||||
| Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | 1 | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Liabilities Current | 5 | 6 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 4 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | 0 | ||||||
| Liabilities | 6 | 6 | 6 | 6 | 5 | 5 | 6 | 7 | 6 | 6 | 6 | 4 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 88 | 85 | 85 | 80 | 75 | 75 | 75 | 71 | 70 | 69 | 69 | 69 | ||||||
| Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -86 | -85 | -82 | -77 | -75 | -74 | -72 | -66 | -64 | -62 | -59 | -56 | ||||||
| Stockholders Equity | 2 | 1 | 3 | 3 | 1 | 2 | 3 | 5 | 6 | 7 | 10 | 13 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 7 | 7 | 10 | 9 | 6 | 7 | 9 | 11 | 12 | 13 | 16 | 16 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialiSpecimen Inc. (ISPC) — SEC Financial Statements & Analysis
iSpecimen Inc. (ISPC) is a services-commercial physical & biological research company, incorporated in DE. iSpecimen Inc. trades on Nasdaq as: ISPC. iSpecimen Inc. (ISPC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, iSpecimen Inc. carries a market cap of $3.70M, a P/E ratio of -0.32x, a P/B ratio of 2.13x, a P/S ratio of 7.92x, an enterprise value of $-718.99K, and an EV/EBITDA multiple of 0.08x. On profitability, it posts a gross margin of -108.26%, an operating margin of -2020.04%, a net margin of -2449.04%, a Return on Equity (ROE) of -968.47%, a Return on Assets (ROA) of -170.10%, and a Return on Invested Capital (ROIC) of -889.57%. Per share, it reports EPS of $-8.19, diluted EPS of $-8.19, free cash flow per share of $-5.02, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -92.11% year-over-year, net income growth of 12.04% year-over-year, and EPS growth of -94.98% year-over-year. On the balance sheet, it maintains a current ratio of 0.82x, a quick ratio of 0.81x, working capital of $-992.54K, a debt-to-equity ratio of 3.26x, a debt ratio of 0.77, an interest coverage ratio of -3139831.00x, free cash flow of $-7.00M (TTM), and net debt of $-4.41M. Figures sourced from SEC EDGAR.
- Market Cap
- $3.70M
- P/E TTM
- -0.32x
- EPS TTM
- $-8.19
- P/B TTM
- 2.13x
- ROE TTM
- -968.47%
- ROA TTM
- -170.10%
- Debt To Equity
- 3.26x
- Free Cash Flow TTM
- $-7.00M
- Net Revenue TTM Growth 1Y
- -92.11%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is iSpecimen Inc. in?
iSpecimen Inc. (ISPC) operates in the Services-Commercial Physical & Biological Research industry.
What exchange does ISPC trade on?
iSpecimen Inc. (ISPC) trades on the Nasdaq.
Where is iSpecimen Inc. incorporated?
iSpecimen Inc. is incorporated in DE.
When was iSpecimen Inc. (ISPC)'s most recent SEC filing?
iSpecimen Inc. (ISPC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ISPC's market cap?
iSpecimen Inc. (ISPC) has a market capitalization of $3.70M as of 2026-06-30.
What is ISPC's EPS (earnings per share)?
iSpecimen Inc. (ISPC)'s trailing twelve month EPS is $-8.19 as of 2026-06-30.
What is ISPC's ROE (return on equity)?
iSpecimen Inc. (ISPC)'s trailing twelve month Return on Equity (ROE) is -968.47% as of 2026-06-30.
What is ISPC's ROA (return on assets)?
iSpecimen Inc. (ISPC)'s trailing twelve month Return on Assets (ROA) is -170.10% as of 2026-06-30.
What is ISPC's ROIC (return on invested capital)?
iSpecimen Inc. (ISPC)'s trailing twelve month Return on Invested Capital (ROIC) is -889.57% as of 2025-12-31.
What is ISPC's EV/EBITDA?
iSpecimen Inc. (ISPC)'s trailing twelve month EV/EBITDA is 0.08x as of 2026-06-30.